Pierre Vandepapeliere


Pierre Vandepapelière, MD, PhD, CEO & CMO

Senior executive leader with over 25 years’ global experience in development of prophylactic and therapeutic vaccines. Pierre has extensive worldwide experience in Pharma and Biotech companies, with leading international roles in clinical development, regulatory & medical affairs, commercial, legal, business development.

Prior to joining Imcyse, Pierre was Vice-President, Chief Medical Officer, at Neovacs and Abivax, Paris, France. He was also a Consultant for other Biotech companies. Previously, Pierre had an 18-year career, with various senior management positions in development of multiple programmes at GlaxoSmithKline Vaccines, Belgium. Pierre joined Imcyse in March 2015

Jean Smal

PhD, Senior Advisor, Development and Manufacturing

Jean Smal, PhD, Senior Advisor, Development and Manufacturing

Senior executive leader with global experience in the R&D and Manufacturing Vaccines Industry. Jean is a bioengineer and a PhD in biochemistry. As Head of Technical Development at GlaxoSmithKline Vaccines, he developed vast experience of the development of new vaccines with an end-to-end view - from the design of the antigens to the final commercial production scale. During the last 10 years he directly contributed to the development and launch of
12 new vaccines. Prior to GSK, Jean occupied various positions from Project Leader to General Manager at Eurogentec (Belgium), a Biotech Company offering services in biopharmaceutical product development and production of GMP lots for clinical trials. Jean joined Imcyse in September 2015

Marcelle Van Mechelen

PhD, Senior Scientific Advisor

Marcelle Van Mechelen, PhD, Senior Scientific Advisor 

Marcelle has 28 years’ experience in immunology, biotechnology and vaccinology. She has a PhD and Post-Doc in immunology on innate and adaptive immunity, from ULB (1987- 1995). Between 1995 and 2015, she worked in Research and Immunology at GSK Vaccines, latterly as Vice President Vaccine Research / Research and Preclinical Development GSK from 2012 onwards. Marcelle joined Imcyse in March 2016.

Vincent Carlier

PhD, R&D Director, Immunology

Vincent Carlier, PhD, R&D Director, Immunology

Vincent has worked for over 20 years on Imcyse technology

Guillaume de Viron


Guillaume de Viron, CFO

Formerly with Deloitte, then CFO of OncoDNA, Masthercell, Univercell

Marie Gérard

Corporate Governance, HR & Finance Director

Marie Gérard, Corporate Governance, HR & Finance Director

After a Master in Business Management at University of Liège, Marie worked for almost 15 years in small biotech companies in the fields of Human Resources Management, Administration, Finance, Corporate Governance and Quality Assurance. Marie joined Imcyse in September 2015. 

Geoffrey Gloire

PhD, IP Director

Geoffrey Gloire, PhD, IP Director & Early Projects Leader

After a PhD in molecular Biology at the University of Liège (Belgium) and a post-doc in Paris (France), Geoffrey was Patent Advisor in Life sciences at ULiege TEchnology Transfer Office from 2011 until 2016 when he joined Imcyse.


Yves Lobet

PhD, Portfolio Director

Yves worked during 25 years at GSK Vaccines in various departments such as preclinical RD, RD partnerships, project management and competitive intelligence. Yves joined Imcyse in September 2015

Luc Vander Elst

PhD, R&D Director, In Vivo and Imotope Development

Luc Vander Elst, PhD, R&D Director, In Vivo and Imotope Development

Luc has worked for over 20 years on the Imcyse technology

Jean Van Rampelbergh

PhD, Clinical Director

Jean Van Ramplebergh, PhD, Clinical Director

Former clinical director Sanofi Belgium , Jean Joined Imcyse in March 2016